Long-acting Octreotide Reduces the Recurrence of Gastrointestinal Bleeding in Patients with a Continuous-Flow Left Ventricular Assist Device

BACKGROUND: Recurrent gastrointestinal bleeding is one of the most significant adverse events in patients with left ventricular assist devices (LVAD). METHODS: We enrolled LVAD patients who had received an intramuscular injection of 20 mg of octreotide LR every 4 weeks as secondary prevention for re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Card Fail
Autores principales: Juricek, Colleen, Imamura, Teruhiko, Nguyen, Ann, Chung, Ben, Rodgers, Daniel, Sarswat, Nitasha, Kim, Gene, Raikhelkar, Jayant, Ota, Takeyohi, Song, Tae, Burkhoff, Daniel, Sayer, Gabriel, Jeevanandam, Valluvan, Uriel, Nir
Formato: Artigo
Lenguaje:Inglês
Publicado: 2018
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5897116/
https://ncbi.nlm.nih.gov/pubmed/29427603
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2018.01.011
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares